Bharat Biotech boasts of Covaxin's 'excellent safety record' amid AstraZeneca row

Amid a row over AstraZeneca's admission of potential side effects of its Covid-19 vaccine, Bharat Biotech said that its Covaxin vaccine was developed with a single-minded focus on safety first, followed by efficacy.
Bharat Biotech boasts of Covaxin's 'excellent safety record' amid AstraZeneca row
Anjali Raj / Jaano Junction

Amid a debate over AstraZeneca's admission that its Covid-19 vaccine, sold as Covishield in India, could cause "rare" side effects, Bharat Biotech, the vaccine maker that developed Covaxin, boasted about its safety record.

The vaccine maker also said that Covaxin was the only Covid-19 vaccine in the government's Covid-19 immunisation programme to have conducted efficacy trials in India.

"Covaxin was evaluated in more than 27,000 subjects as part of its licensure process. It was licensed under restricted use in clinical trial mode, where detailed safety reporting was carried out for several hundred thousand subjects," Bharat Biotech said.

"Safety of Covaxin was also evaluated by the Ministry of Health, Government of India. Ongoing safety monitoring (pharmacovigilance) was continued throughout the product life cycle of Covaxin," it stated.

As seasoned innovators and product developers, the Bharat Biotech team was well aware that, while the efficacy of Covid-19 vaccines may be short-lived, the impact on patient safety could last a lifetime. Hence, safety is the primary focus for all our vaccines," it further said.

Also Read
Violent protests at US universities over Gaza war, hundreds arrested at Columbia
Bharat Biotech boasts of Covaxin's 'excellent safety record' amid AstraZeneca row

The pharmaceutical company was facing a class-action lawsuit alleging serious injuries and deaths resulting from its vaccine, developed in collaboration with the University of Oxford.

Source: India Today

Stay connected to Jaano Junction on Instagram, Facebook, YouTube, Twitter and Koo. Listen to our Podcast on Spotify or Apple Podcasts.

Related Stories

No stories found.
logo
Jaano Junction
www.jaanojunction.com